Royal Bank Of Canada Cassava Sciences Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Cassava Sciences Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 8,115 shares of SAVA stock, worth $34,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,115

Previous 8,491 4.43%

Holding current value

$34,813

Previous $104,000 128.85%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.57 - $35.08 $3,598 - $13,190	-376 Reduced 4.43%	8,115 $238,000
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $49,708 - $105,092	4,025 Added 90.13%	8,491 $104,000
Q1 2024 Nov 05, 2024	SELL	$18.44 - $26.41 $74,221 - $106,300	-4,025 Reduced 47.4%	4,466 $90,000
Q1 2024 May 15, 2024	SELL	$18.44 - $26.41 $200,553 - $287,235	-10,876 Reduced 70.89%	4,466 $90,000
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $77,571 - $184,785	6,137 Added 66.67%	15,342 $345,000
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $47,024 - $71,554	2,826 Added 44.3%	9,205 $153,000
Q2 2023 Aug 14, 2023	BUY	$21.59 - $27.88 $11,896 - $15,361	551 Added 9.45%	6,379 $156,000
Q1 2023 May 15, 2023	SELL	$23.46 - $36.44 $79,998 - $124,260	-3,410 Reduced 36.91%	5,828 $140,000
Q4 2022 Feb 14, 2023	BUY	$27.82 - $44.16 $135,928 - $215,765	4,886 Added 112.27%	9,238 $272,000
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $13,031 - $40,745	-798 Reduced 15.5%	4,352 $183,000
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $7,439 - $16,619	-432 Reduced 7.74%	5,150 $145,000
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $142,266 - $231,510	-4,364 Reduced 43.88%	5,582 $208,000
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $193,483 - $478,368	5,262 Added 112.34%	9,946 $434,000
Q3 2021 Nov 15, 2021	SELL	$41.79 - $135.3 $22,650 - $73,332	-542 Reduced 10.37%	4,684 $291,000
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $168,015 - $468,876	5,226 New	5,226 $447,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $172M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Cassava Sciences Inc Transaction History